RxDoctor Payments Data

Stacey Rifkin-Zenenberg

Hospice and Palliative Medicine · Hackensack, NJNPI 1376519157

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (57.9%), speaking fees and food and beverage — rather than concentrated in one kind of arrangement. 9 manufacturers reported payments, led by Global Blood Therapeutics, Inc. at 36.1% of the total. 2025 is the largest year on record at $6,790, more than ten times the $135 reported in 2019. Among hospice and palliative medicine clinicians in NJ with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$18,663in general payments, 2019–2025

Across 31 payments — averaging $602.03 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Global Blood Therapeutics, Inc.$7K
  • Genetix Biotherapeutics Inc$7K
  • Vertex$5K
  • Sanofi$200
  • Novartis$135
  • Novo Nordisk$125
  • plus $57 from 3 others
$643,587in research payments, 2019–2025

Across 81 payments — averaging $7945.52 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Genetix Biotherapeutics Inc$319K
  • Sanofi$243K
  • Pfizer$44K
  • Novartis$27K
  • Global Blood Therapeutics, Inc.$11K

What the payments were for

  • Consulting fees$10,80258%
  • Speaking & faculty fees$5,42529%
  • Travel & lodging$1,2016%
  • Food & beverage$1,2357%

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Global Blood Therapeutics, Inc.5$6,733
Genetix Biotherapeutics Inc9$6,573
Vertex7$4,840
Sanofi5$200
Novartis1$135
Novo Nordisk1$125
RARE Disease Therapeutics, Inc.1$23
Pfizer1$19
Medunik USA Inc.1$16

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$18,663 in reported general payments places this provider in the 95th percentile of 38 hospice and palliative medicine providers in New Jersey.

See all hospice and palliative medicine providers in New Jersey

Other hospice and palliative medicine in Hackensack

See the full list for New Jersey

Where these figures come from

Is this you, or does something look wrong? →